But negative result doesn't rule out disease, FDA warns
The U.S.
Food and Drug Administration has approved a new test that may help
doctors diagnose type 1 diabetes, the most common form diagnosed in
children and adolescents.
The Kronus ZnT8Ab Elisa Assay may help some people with type 1
diabetes receive faster diagnosis and treatment, the FDA said in a news
release. People with type 1 diabetes produce little or no insulin
because cells in the pancreas that produce the hormone are mistakenly
attacked by the body's immune system.
Insulin is a hormone that converts sugars (glucose) in food to fuel
for the body. People who lack the hormone must inject insulin to
regulate blood glucose and lower their risk of potential complications,
including blindness, kidney failure and heart disease.
The test was able to diagnose a key marker in 65 percent of samples
from people diagnosed with type 1 diabetes, and incorrectly gave a
positive result in less than 2 percent of samples, the FDA said.
On the other hand, the agency stressed that negative test result
should not rule out a diagnosis of type 1 diabetes. The test also
shouldn't be used to monitor the body's response to treatment, the FDA
added.
The new test is produced by Kronus Market Development Associates, based in Star, Idaho.
تعليقات
إرسال تعليق